ACTHAR Gel for Chronic Pulmonary Sarcoidosis (ACPS)

Trial Profile

ACTHAR Gel for Chronic Pulmonary Sarcoidosis (ACPS)

Phase of Trial: Phase IV

Latest Information Update: 05 Dec 2017

At a glance

  • Drugs Corticotropin (Primary)
  • Indications Pulmonary sarcoidosis
  • Focus Adverse reactions
  • Most Recent Events

    • 27 Jan 2015 Planned End Date changed from 1 Dec 2016 to 1 Sep 2017 as reported by record.
    • 27 Jan 2015 Planned primary completion date changed from 1 Jun 2016 to 1 Dec 2016 as reported by record.
    • 16 Jul 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top